Joly, Florence
Lefeuvre-Plesse, Claudia
Garnier-Tixidre, Claire
Helissey, Carole
Menneveau, Nathalie
Zannetti, Alain
Salas, Sebastien
Houede, Nadine
Abadie-Lacourtoisie, Sophie
Stefani, Laetitia
Nenan, Soazig
Rieger, Isabelle
Durand-Zaleski, Isabelle
Descotes, Jean-Marc
Anota, Amélie
Funding for this research was provided by:
Ligue Contre le Cancer
Article History
Received: 16 July 2020
Accepted: 4 September 2020
First Online: 9 October 2020
Ethics approval and consent to participate
: This study (ExternalRef removed NCT03169075) has been approved by a French ethic committee (Comité de Protection des Personnes Nord Ouest III: 2016–47) and the Agence Nationale de sécurité du médicament (ID-RCB 2009–012942-22). This study is performed in accordance with the Declaration of Helsinki and Good Clinical Practice Guidelines. Written informed consent is obtained from each participant prior to participation in the study.
: Not applicable
: The authors declare that they have no competing interests.